Healthcare provider profile · identity verified

Benjamin R Snell, MD

Family Practice · LANCASTER, PA · NPI 1043504848

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	685	188
Omeprazole	Omeprazole	290	74
Albuterol Sulfate Hfa	Albuterol Sulfate	289	87
Metformin Hcl	Metformin Hcl	287	78
Lisinopril	Lisinopril	254	78
Levothyroxine Sodium	Levothyroxine Sodium	236	59
Trulicity	Dulaglutide	206	38
Fluticasone Propionate	Fluticasone Propionate	192	79
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	174	20
Amlodipine Besylate	Amlodipine Besylate	172	52
Metformin Hcl Er	Metformin Hcl	153	46
Jardiance	Empagliflozin	148	33
Bupropion Xl	Bupropion Hcl	146	27
Gabapentin	Gabapentin	143	41
Famotidine	Famotidine	138	46
Metoprolol Succinate	Metoprolol Succinate	133	34
Losartan Potassium	Losartan Potassium	126	32
Tamsulosin Hcl	Tamsulosin Hcl	125	33
Montelukast Sodium	Montelukast Sodium	121	35
Trazodone Hcl	Trazodone Hcl	112	36
Alendronate Sodium	Alendronate Sodium	110	25
Sertraline Hcl	Sertraline Hcl	94	24
Alprazolam	Alprazolam	93	13
Lorazepam	Lorazepam	93	13
Pantoprazole Sodium	Pantoprazole Sodium	92	23
Hydrochlorothiazide	Hydrochlorothiazide	90	26
Triamcinolone Acetonide	Triamcinolone Acetonide	87	50
Mounjaro	Tirzepatide	86	13
Propranolol Hcl	Propranolol Hcl	80	23
Rosuvastatin Calcium	Rosuvastatin Calcium	80	19
Baclofen	Baclofen	79	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	21
Escitalopram Oxalate	Escitalopram Oxalate	76	20
Hydroxyzine Hcl	Hydroxyzine Hcl	76	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	15
Mirtazapine	Mirtazapine	75	22
Duloxetine Hcl	Duloxetine Hcl	74	16
Metoprolol Tartrate	Metoprolol Tartrate	74	18
Furosemide	Furosemide	73	17
Ipratropium Bromide	Ipratropium Bromide	73	53
Spironolactone	Spironolactone	72	20
Varenicline Tartrate	Varenicline Tartrate	72	21
Fluoxetine Hcl	Fluoxetine Hcl	70	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	15
Clonazepam	Clonazepam	68	13
Quetiapine Fumarate	Quetiapine Fumarate	65	11
Pravastatin Sodium	Pravastatin Sodium	59	16
Eliquis	Apixaban	58	15
Pregabalin	Pregabalin	57	12
Carvedilol	Carvedilol	54	14
Buspirone Hcl	Buspirone Hcl	52	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	13
Myrbetriq	Mirabegron	52	suppressed
Clopidogrel	Clopidogrel Bisulfate	51	13
Simvastatin	Simvastatin	46	16
Prednisone	Prednisone	45	31
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Bupropion Hcl Sr	Bupropion Hcl	44	11
Citalopram Hbr	Citalopram Hydrobromide	43	11
Diclofenac Sodium	Diclofenac Sodium	41	24
Aripiprazole	Aripiprazole	40	suppressed
Diazepam	Diazepam	40	suppressed
Ozempic	Semaglutide	39	13
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Loperamide	Loperamide Hcl	35	17
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	23
Carbamazepine Er	Carbamazepine	30	suppressed
Topiramate	Topiramate	30	suppressed
Finasteride	Finasteride	29	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	24	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	24	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Naproxen	Naproxen	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Testosterone	Testosterone	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Glipizide	Glipizide	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error